Stocktoria

NEUTRA CORP. NTRR

OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2011-07-12

NEUTRA CORP. financials (annual, from 10-K)

Revenue
2014201520162017201820192020202120222023
Net income
2014201520162017201820192020202120222023
Free cash flow
2014201520162017201820192020202120222023

Bars are annual figures from 2014 to 2023; red bars are negative (a loss or cash outflow).

MetricFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$67,996$92,014$9,687
Gross profit$35,306$31,161-$33,257
Operating income-$297,675-$583,582-$478,665-$1.7M-$163,684-$370,726-$1.0M-$635,866
Interest expense$62,063$60,606$121,648$720,750$355,348$497,155$401,608$1.2M
Income tax$3,523$3,523$0
Net income-$561,417-$632,926-$538,892-$2.4M-$519,032-$867,881-$1.4M-$1.9M-$2.1M
Operating cash flow-$153,243-$405,615-$412,378-$417,000-$108,925-$211,621-$491,718-$546,538
Free cash flow-$445,842-$608,868
Cash & equivalents$1,969$1,056$23,308$177,176$0$0$0$284$6,584$114,101
Inventory$23,846$3,500
Total assets$75,175$130,932$190,767$182,334$163,596$12,325$0$284$6,584$114,101
Total liabilities$813,795$1.2M$1.0M$1.0M$1.3M$776,797$675,556$425,583$392,539$529,502
Shareholders' equity-$773,820-$1.3M-$967,476-$849,490-$1.1M-$764,472-$675,556-$425,299-$385,955-$415,401

Growth · year-over-year · Revenue CAGR 164.9%

MetricFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue growth-26.1%+849.9%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Source: SEC EDGAR filings · CIK 0001512886 · US · as of 2023-01-31. facts plus Stocktoria's own computed scores — not investment advice.